Structure

Physi-Chem Properties

Molecular Weight:  206.17
Volume:  243.025
LogP:  4.832
LogD:  4.333
LogS:  -4.599
# Rotatable Bonds:  2
TPSA:  20.23
# H-Bond Aceptor:  1
# H-Bond Donor:  1
# Rings:  1
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.68
Synthetic Accessibility Score:  2.015
Fsp3:  0.571
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.048
MDCK Permeability:  1.0667621609172784e-05
Pgp-inhibitor:  0.585
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.727
20% Bioavailability (F20%):  0.989
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.294
Plasma Protein Binding (PPB):  98.43366241455078%
Volume Distribution (VD):  4.896
Pgp-substrate:  4.953541278839111%

ADMET: Metabolism

CYP1A2-inhibitor:  0.907
CYP1A2-substrate:  0.935
CYP2C19-inhibitor:  0.77
CYP2C19-substrate:  0.779
CYP2C9-inhibitor:  0.633
CYP2C9-substrate:  0.872
CYP2D6-inhibitor:  0.885
CYP2D6-substrate:  0.864
CYP3A4-inhibitor:  0.429
CYP3A4-substrate:  0.669

ADMET: Excretion

Clearance (CL):  6.3
Half-life (T1/2):  0.324

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.041
Drug-inuced Liver Injury (DILI):  0.04
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.146
Maximum Recommended Daily Dose:  0.744
Skin Sensitization:  0.739
Carcinogencity:  0.034
Eye Corrosion:  0.983
Eye Irritation:  0.986
Respiratory Toxicity:  0.699

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC252821

Natural Product ID:  NPC252821
Common Name*:   2,4-Ditert-Butylphenol
IUPAC Name:   2,4-ditert-butylphenol
Synonyms:  
Standard InCHIKey:  ICKWICRCANNIBI-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C14H22O/c1-13(2,3)10-7-8-12(15)11(9-10)14(4,5)6/h7-9,15H,1-6H3
SMILES:  Oc1ccc(cc1C(C)(C)C)C(C)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL29873
PubChem CID:   7311
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0002811] Phenylpropanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus log(1/ID50) = 4.24 n.a. PMID[484291]
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 13800.6 nM PubChem BioAssay data set
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 30637.9 nM PubChem BioAssay data set
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 61396 nM PubChem BioAssay data set
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 30513.3 nM PubChem BioAssay data set
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 60882 nM PubChem BioAssay data set
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 54482.7 nM PubChem BioAssay data set
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 48966.2 nM PubChem BioAssay data set
NPT162 Individual Protein Heat shock protein beta-1 Homo sapiens Potency n.a. 54719.2 nM PubChem BioAssay data set
NPT162 Individual Protein Heat shock protein beta-1 Homo sapiens Potency n.a. 48966.2 nM PubChem BioAssay data set
NPT106 Individual Protein Peroxisome proliferator-activated receptor delta Homo sapiens Potency n.a. 48966.2 nM PubChem BioAssay data set
NPT163 Individual Protein Nuclear factor NF-kappa-B p105 subunit Homo sapiens Potency n.a. 43465 nM PubChem BioAssay data set
NPT163 Individual Protein Nuclear factor NF-kappa-B p105 subunit Homo sapiens Potency n.a. 43641.2 nM PubChem BioAssay data set
NPT1007 Protein Complex GABA-A receptor; alpha-1/beta-2/gamma-2 Homo sapiens EC50 = 100000000.0 nM PMID[484289]
NPT693 Organism Xenopus laevis Xenopus laevis EC50 = 100000000.0 nM PMID[484289]
NPT35 Others n.a. CLogP = 5.1 n.a. PMID[484289]
NPT32 Organism Mus musculus Mus musculus HD50 = 40.0 mg kg-1 PMID[484290]
NPT32 Organism Mus musculus Mus musculus LD50 = 100.0 mg.kg-1 PMID[484290]
NPT610 Others Molecular identity unknown Potency n.a. 70794.6 nM PMID[484292]
NPT2 Others Unspecified Potency n.a. 27535.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 24442.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 38738.3 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 48966.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 43641.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 68589.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 60882 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 385.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 54941 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 54719.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 43277.1 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 61396 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 2719.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 3063.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 27195 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 30637.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 54261.1 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 48557.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 30513.3 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 24336.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 68310.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 61130.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 76958.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 17373.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 7760.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 34525.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 27306 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 30895.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 43465 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 38895.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 54482.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 1082.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 48768.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 48360.3 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 24237.6 nM PubChem BioAssay data set
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens Potency n.a. 19415.1 nM PubChem BioAssay data set
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens Potency n.a. 48966.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 21784.1 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 24541.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 61644.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 21872.4 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 15292.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 12197.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 43101.1 nM PubChem BioAssay data set

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC252821 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC122005
0.9892 High Similarity NPC225506
0.9677 High Similarity NPC77492
0.9674 High Similarity NPC144682
0.9565 High Similarity NPC289769
0.9565 High Similarity NPC152415
0.9565 High Similarity NPC27323
0.9565 High Similarity NPC316301
0.9462 High Similarity NPC8392
0.9348 High Similarity NPC155908
0.9348 High Similarity NPC306074
0.9348 High Similarity NPC204210
0.9271 High Similarity NPC211885
0.9263 High Similarity NPC225464
0.9255 High Similarity NPC222146
0.9167 High Similarity NPC92730
0.9167 High Similarity NPC33675
0.9167 High Similarity NPC299762
0.9167 High Similarity NPC128723
0.914 High Similarity NPC304541
0.913 High Similarity NPC242240
0.913 High Similarity NPC318325
0.913 High Similarity NPC123273
0.913 High Similarity NPC70436
0.9091 High Similarity NPC138942
0.9082 High Similarity NPC269212
0.9082 High Similarity NPC168829
0.9043 High Similarity NPC55903
0.9022 High Similarity NPC25493
0.9022 High Similarity NPC113460
0.902 High Similarity NPC13482
0.9 High Similarity NPC271274
0.899 High Similarity NPC288411
0.898 High Similarity NPC252105
0.8925 High Similarity NPC258219
0.8925 High Similarity NPC280347
0.8925 High Similarity NPC98772
0.8925 High Similarity NPC177420
0.8913 High Similarity NPC407
0.8913 High Similarity NPC184169
0.8913 High Similarity NPC307235
0.8913 High Similarity NPC23167
0.89 High Similarity NPC219286
0.89 High Similarity NPC99557
0.8866 High Similarity NPC79241
0.8866 High Similarity NPC6597
0.8846 High Similarity NPC250323
0.8846 High Similarity NPC228425
0.8835 High Similarity NPC141782
0.883 High Similarity NPC55561
0.8824 High Similarity NPC470039
0.8812 High Similarity NPC21594
0.8804 High Similarity NPC197783
0.8804 High Similarity NPC155393
0.8763 High Similarity NPC312132
0.8763 High Similarity NPC259512
0.875 High Similarity NPC260323
0.875 High Similarity NPC128062
0.875 High Similarity NPC176279
0.875 High Similarity NPC245187
0.8738 High Similarity NPC58865
0.8737 High Similarity NPC270547
0.8725 High Similarity NPC228737
0.8725 High Similarity NPC151477
0.8713 High Similarity NPC303141
0.8713 High Similarity NPC47284
0.87 High Similarity NPC108497
0.8696 High Similarity NPC286904
0.8696 High Similarity NPC175313
0.8696 High Similarity NPC248817
0.8687 High Similarity NPC72729
0.8679 High Similarity NPC195922
0.866 High Similarity NPC26244
0.8654 High Similarity NPC296683
0.8646 High Similarity NPC3358
0.8646 High Similarity NPC271440
0.8646 High Similarity NPC147284
0.8646 High Similarity NPC306884
0.8646 High Similarity NPC162314
0.8646 High Similarity NPC210497
0.8646 High Similarity NPC94139
0.8641 High Similarity NPC262365
0.8632 High Similarity NPC192
0.8627 High Similarity NPC310456
0.8627 High Similarity NPC477814
0.8627 High Similarity NPC54765
0.8627 High Similarity NPC53740
0.8617 High Similarity NPC19680
0.8617 High Similarity NPC27974
0.8614 High Similarity NPC120719
0.86 High Similarity NPC51015
0.8587 High Similarity NPC265146
0.8587 High Similarity NPC124436
0.8571 High Similarity NPC82664
0.8571 High Similarity NPC216520
0.8571 High Similarity NPC95716
0.8571 High Similarity NPC132271
0.8571 High Similarity NPC473388
0.8571 High Similarity NPC292730
0.8557 High Similarity NPC151715
0.8544 High Similarity NPC320439
0.8542 High Similarity NPC45040
0.8542 High Similarity NPC231150
0.8529 High Similarity NPC117115
0.8529 High Similarity NPC243677
0.8515 High Similarity NPC470202
0.8505 High Similarity NPC268160
0.85 High Similarity NPC48730
0.85 High Similarity NPC248396
0.85 High Similarity NPC129373
0.8491 Intermediate Similarity NPC46940
0.8485 Intermediate Similarity NPC152097
0.8476 Intermediate Similarity NPC44732
0.8469 Intermediate Similarity NPC274678
0.8462 Intermediate Similarity NPC61885
0.8462 Intermediate Similarity NPC95344
0.8462 Intermediate Similarity NPC306295
0.8462 Intermediate Similarity NPC64586
0.8462 Intermediate Similarity NPC63698
0.8454 Intermediate Similarity NPC325292
0.8454 Intermediate Similarity NPC138117
0.8447 Intermediate Similarity NPC155072
0.844 Intermediate Similarity NPC477136
0.8438 Intermediate Similarity NPC300017
0.8431 Intermediate Similarity NPC475225
0.8431 Intermediate Similarity NPC272029
0.8431 Intermediate Similarity NPC238696
0.8426 Intermediate Similarity NPC35797
0.8426 Intermediate Similarity NPC192948
0.8426 Intermediate Similarity NPC147179
0.8416 Intermediate Similarity NPC471578
0.8416 Intermediate Similarity NPC101025
0.8411 Intermediate Similarity NPC35344
0.8411 Intermediate Similarity NPC715
0.8411 Intermediate Similarity NPC141003
0.84 Intermediate Similarity NPC80027
0.84 Intermediate Similarity NPC260775
0.8396 Intermediate Similarity NPC151537
0.8396 Intermediate Similarity NPC266937
0.8396 Intermediate Similarity NPC225679
0.8396 Intermediate Similarity NPC165770
0.8396 Intermediate Similarity NPC308689
0.8396 Intermediate Similarity NPC4493
0.8396 Intermediate Similarity NPC322753
0.8396 Intermediate Similarity NPC77772
0.8396 Intermediate Similarity NPC476632
0.8396 Intermediate Similarity NPC470770
0.8384 Intermediate Similarity NPC202986
0.8381 Intermediate Similarity NPC314187
0.8381 Intermediate Similarity NPC75272
0.8381 Intermediate Similarity NPC471954
0.8367 Intermediate Similarity NPC76938
0.8349 Intermediate Similarity NPC477137
0.8349 Intermediate Similarity NPC38893
0.8349 Intermediate Similarity NPC219112
0.8349 Intermediate Similarity NPC308828
0.8349 Intermediate Similarity NPC308311
0.8349 Intermediate Similarity NPC471668
0.8333 Intermediate Similarity NPC62351
0.8333 Intermediate Similarity NPC471228
0.8333 Intermediate Similarity NPC107240
0.8333 Intermediate Similarity NPC12656
0.8333 Intermediate Similarity NPC235762
0.8318 Intermediate Similarity NPC98372
0.8318 Intermediate Similarity NPC228988
0.8318 Intermediate Similarity NPC62867
0.8318 Intermediate Similarity NPC286222
0.8318 Intermediate Similarity NPC43525
0.8318 Intermediate Similarity NPC177962
0.8317 Intermediate Similarity NPC130756
0.8317 Intermediate Similarity NPC174911
0.8317 Intermediate Similarity NPC12931
0.8317 Intermediate Similarity NPC70677
0.8302 Intermediate Similarity NPC224870
0.83 Intermediate Similarity NPC156313
0.83 Intermediate Similarity NPC475078
0.83 Intermediate Similarity NPC32674
0.83 Intermediate Similarity NPC474073
0.8298 Intermediate Similarity NPC150837
0.8286 Intermediate Similarity NPC11554
0.8283 Intermediate Similarity NPC32714
0.8283 Intermediate Similarity NPC313650
0.8273 Intermediate Similarity NPC304510
0.8273 Intermediate Similarity NPC172219
0.8273 Intermediate Similarity NPC16030
0.8269 Intermediate Similarity NPC469913
0.8269 Intermediate Similarity NPC248904
0.8265 Intermediate Similarity NPC29373
0.8257 Intermediate Similarity NPC474486
0.8252 Intermediate Similarity NPC119860
0.8252 Intermediate Similarity NPC475580
0.8241 Intermediate Similarity NPC117846
0.8241 Intermediate Similarity NPC263753
0.8235 Intermediate Similarity NPC12221
0.8235 Intermediate Similarity NPC472585
0.8235 Intermediate Similarity NPC477685
0.8229 Intermediate Similarity NPC104216
0.8224 Intermediate Similarity NPC275627
0.8218 Intermediate Similarity NPC78119
0.8218 Intermediate Similarity NPC51333

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC252821 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9674 High Similarity NPD1809 Phase 2
0.9565 High Similarity NPD1432 Clinical (unspecified phase)
0.9247 High Similarity NPD845 Approved
0.8878 High Similarity NPD289 Clinical (unspecified phase)
0.8854 High Similarity NPD844 Approved
0.8776 High Similarity NPD3020 Approved
0.8763 High Similarity NPD288 Approved
0.866 High Similarity NPD2859 Approved
0.866 High Similarity NPD2860 Approved
0.86 High Similarity NPD940 Approved
0.86 High Similarity NPD846 Approved
0.8587 High Similarity NPD111 Approved
0.8557 High Similarity NPD2934 Approved
0.8557 High Similarity NPD2933 Approved
0.8396 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.8241 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD4589 Approved
0.8037 Intermediate Similarity NPD3022 Approved
0.8037 Intermediate Similarity NPD3021 Approved
0.8019 Intermediate Similarity NPD2342 Discontinued
0.7982 Intermediate Similarity NPD7635 Approved
0.7925 Intermediate Similarity NPD1444 Approved
0.7925 Intermediate Similarity NPD1445 Approved
0.7876 Intermediate Similarity NPD5304 Approved
0.7876 Intermediate Similarity NPD3091 Approved
0.7876 Intermediate Similarity NPD5303 Approved
0.787 Intermediate Similarity NPD4750 Phase 3
0.7807 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7807 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD2228 Approved
0.7748 Intermediate Similarity NPD2234 Approved
0.7748 Intermediate Similarity NPD2229 Approved
0.7739 Intermediate Similarity NPD2932 Approved
0.7739 Intermediate Similarity NPD3019 Approved
0.7739 Intermediate Similarity NPD4059 Approved
0.7739 Intermediate Similarity NPD1751 Approved
0.7736 Intermediate Similarity NPD9610 Approved
0.7736 Intermediate Similarity NPD9608 Approved
0.7706 Intermediate Similarity NPD1792 Phase 2
0.7679 Intermediate Similarity NPD1793 Approved
0.7679 Intermediate Similarity NPD1791 Approved
0.7672 Intermediate Similarity NPD3143 Discontinued
0.7672 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD9500 Approved
0.7627 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD1242 Phase 1
0.7607 Intermediate Similarity NPD3092 Approved
0.7586 Intermediate Similarity NPD4626 Approved
0.7565 Intermediate Similarity NPD7330 Discontinued
0.7542 Intermediate Similarity NPD3070 Discontinued
0.75 Intermediate Similarity NPD4093 Discontinued
0.7456 Intermediate Similarity NPD6671 Approved
0.7456 Intermediate Similarity NPD7157 Approved
0.7453 Intermediate Similarity NPD3028 Approved
0.7436 Intermediate Similarity NPD3095 Discontinued
0.7429 Intermediate Similarity NPD9273 Approved
0.7411 Intermediate Similarity NPD228 Approved
0.7391 Intermediate Similarity NPD9087 Approved
0.7391 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD7636 Approved
0.7355 Intermediate Similarity NPD3094 Phase 2
0.7297 Intermediate Similarity NPD2684 Approved
0.7295 Intermediate Similarity NPD2194 Approved
0.7295 Intermediate Similarity NPD2195 Approved
0.7288 Intermediate Similarity NPD2286 Discontinued
0.7273 Intermediate Similarity NPD6696 Suspended
0.7265 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD3635 Approved
0.7236 Intermediate Similarity NPD3637 Approved
0.7236 Intermediate Similarity NPD4212 Discontinued
0.7236 Intermediate Similarity NPD4208 Discontinued
0.7236 Intermediate Similarity NPD3636 Approved
0.7236 Intermediate Similarity NPD5736 Approved
0.7232 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD497 Approved
0.7217 Intermediate Similarity NPD1476 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD475 Phase 2
0.7213 Intermediate Similarity NPD1135 Approved
0.7213 Intermediate Similarity NPD1164 Approved
0.7213 Intermediate Similarity NPD1133 Approved
0.7213 Intermediate Similarity NPD1134 Approved
0.7213 Intermediate Similarity NPD1131 Approved
0.7213 Intermediate Similarity NPD1129 Approved
0.7203 Intermediate Similarity NPD5691 Approved
0.72 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD9377 Approved
0.7193 Intermediate Similarity NPD1138 Approved
0.7193 Intermediate Similarity NPD9379 Approved
0.7177 Intermediate Similarity NPD2606 Approved
0.7177 Intermediate Similarity NPD2605 Approved
0.7177 Intermediate Similarity NPD4207 Discontinued
0.7167 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD1610 Phase 2
0.7167 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD9294 Approved
0.7156 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7155 Intermediate Similarity NPD256 Approved
0.7155 Intermediate Similarity NPD255 Approved
0.7131 Intermediate Similarity NPD8651 Approved
0.713 Intermediate Similarity NPD498 Approved
0.713 Intermediate Similarity NPD495 Approved
0.713 Intermediate Similarity NPD496 Approved
0.712 Intermediate Similarity NPD5156 Approved
0.712 Intermediate Similarity NPD5155 Approved
0.7109 Intermediate Similarity NPD4097 Suspended
0.7105 Intermediate Similarity NPD1139 Approved
0.7105 Intermediate Similarity NPD1137 Approved
0.7087 Intermediate Similarity NPD4060 Phase 1
0.7083 Intermediate Similarity NPD9088 Approved
0.7083 Intermediate Similarity NPD3026 Approved
0.7083 Intermediate Similarity NPD3023 Approved
0.7059 Intermediate Similarity NPD3025 Approved
0.7059 Intermediate Similarity NPD3024 Approved
0.7054 Intermediate Similarity NPD290 Approved
0.7049 Intermediate Similarity NPD1755 Approved
0.7043 Intermediate Similarity NPD7843 Approved
0.7043 Intermediate Similarity NPD821 Approved
0.704 Intermediate Similarity NPD3594 Approved
0.704 Intermediate Similarity NPD3595 Approved
0.704 Intermediate Similarity NPD4908 Phase 1
0.7034 Intermediate Similarity NPD856 Approved
0.7034 Intermediate Similarity NPD16 Approved
0.7025 Intermediate Similarity NPD1201 Approved
0.7016 Intermediate Similarity NPD3690 Phase 2
0.7016 Intermediate Similarity NPD3691 Phase 2
0.7016 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD4624 Approved
0.7008 Intermediate Similarity NPD6663 Approved
0.7 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2668 Approved
0.7 Intermediate Similarity NPD2667 Approved
0.6984 Remote Similarity NPD4625 Phase 3
0.6983 Remote Similarity NPD1398 Phase 1
0.6983 Remote Similarity NPD5283 Phase 1
0.6975 Remote Similarity NPD1548 Phase 1
0.6964 Remote Similarity NPD968 Approved
0.696 Remote Similarity NPD2861 Phase 2
0.6949 Remote Similarity NPD405 Clinical (unspecified phase)
0.6935 Remote Similarity NPD4339 Clinical (unspecified phase)
0.693 Remote Similarity NPD5451 Approved
0.6929 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6923 Remote Similarity NPD9618 Approved
0.6923 Remote Similarity NPD9614 Approved
0.6917 Remote Similarity NPD1357 Approved
0.6917 Remote Similarity NPD1651 Approved
0.6911 Remote Similarity NPD1669 Approved
0.6911 Remote Similarity NPD4749 Approved
0.6903 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6891 Remote Similarity NPD317 Approved
0.6891 Remote Similarity NPD318 Approved
0.6885 Remote Similarity NPD422 Phase 1
0.6875 Remote Similarity NPD6407 Approved
0.6875 Remote Similarity NPD6405 Approved
0.687 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6864 Remote Similarity NPD709 Approved
0.6864 Remote Similarity NPD6387 Discontinued
0.686 Remote Similarity NPD1778 Approved
0.6855 Remote Similarity NPD1283 Approved
0.6842 Remote Similarity NPD9266 Approved
0.6842 Remote Similarity NPD74 Approved
0.6833 Remote Similarity NPD1759 Phase 1
0.6829 Remote Similarity NPD2230 Approved
0.6829 Remote Similarity NPD2233 Approved
0.6829 Remote Similarity NPD2232 Approved
0.6822 Remote Similarity NPD3620 Phase 2
0.6822 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6818 Remote Similarity NPD1616 Discontinued
0.6807 Remote Similarity NPD9493 Approved
0.6807 Remote Similarity NPD7340 Approved
0.6807 Remote Similarity NPD9568 Approved
0.6803 Remote Similarity NPD3496 Discontinued
0.68 Remote Similarity NPD9089 Approved
0.68 Remote Similarity NPD4104 Clinical (unspecified phase)
0.68 Remote Similarity NPD1470 Approved
0.68 Remote Similarity NPD4103 Phase 2
0.6792 Remote Similarity NPD159 Clinical (unspecified phase)
0.6774 Remote Similarity NPD4659 Approved
0.6774 Remote Similarity NPD6583 Phase 3
0.6774 Remote Similarity NPD6582 Phase 2
0.6774 Remote Similarity NPD5327 Phase 3
0.6765 Remote Similarity NPD5734 Clinical (unspecified phase)
0.6757 Remote Similarity NPD4818 Approved
0.6757 Remote Similarity NPD4817 Approved
0.6754 Remote Similarity NPD9267 Approved
0.6754 Remote Similarity NPD9263 Approved
0.6754 Remote Similarity NPD9264 Approved
0.6752 Remote Similarity NPD5535 Approved
0.675 Remote Similarity NPD1758 Phase 1
0.675 Remote Similarity NPD9616 Approved
0.675 Remote Similarity NPD9613 Approved
0.675 Remote Similarity NPD9615 Approved
0.6746 Remote Similarity NPD6584 Phase 3
0.6744 Remote Similarity NPD4248 Discontinued
0.6742 Remote Similarity NPD7742 Approved
0.6742 Remote Similarity NPD7743 Approved
0.6741 Remote Similarity NPD7003 Approved
0.6721 Remote Similarity NPD9381 Approved
0.6721 Remote Similarity NPD9384 Approved
0.6719 Remote Similarity NPD7095 Approved
0.6718 Remote Similarity NPD2157 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data